ResearchMoz

Sciatic Pain Global Clinical Trials Review, H2, 2014

GlobalData
Published Date » 2014-07-31
No. Of Pages » 67
   
 GlobalData's clinical trial report, Sciatic Pain Global Clinical Trials Review, H2, 2014" provides data on the Sciatic Pain clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Sciatic Pain. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Sciatic Pain. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts....
Table of Content

Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Sciatic Pain 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Sciatic Pain to Central Nervous System Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Sciatic Pain to Central Nervous System Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Subjects Recruited Over a Period of Time 25
Clinical Trials by Sponsor Type 26
Prominent Sponsors 27
Top Companies Participating in Sciatic Pain Therapeutics Clinical Trials 28
Prominent Drugs 29
Clinical Trial Profiles 30
Clinical Trial Overview of Top Companies 30
Biogen Idec Inc. 30
Clinical Trial Overview of Biogen Idec Inc. 30
Teva Pharmaceutical Industries Limited 31
Clinical Trial Overview of Teva Pharmaceutical Industries Limited 31
Regeneron Pharmaceuticals, Inc. 32
Clinical Trial Overview of Regeneron Pharmaceuticals, Inc. 32
Evotec AG 33
Clinical Trial Overview of Evotec AG 33
Eurofarma Laboratorios S.A. 34
Clinical Trial Overview of Eurofarma Laboratorios S.A. 34
Clalit Health Services 35
Clinical Trial Overview of Clalit Health Services 35
Calzada Limited 36
Clinical Trial Overview of Calzada Limited 36
Clinical Trial Overview of Top Institutes / Government 37
University Hospital Freiburg 37
Clinical Trial Overview of University Hospital Freiburg 37
Kaiser Permanente 38
Clinical Trial Overview of Kaiser Permanente 38
National Institute of Dental and Craniofacial Research 39
Clinical Trial Overview of National Institute of Dental and Craniofacial Research 39
Wenzhou Medical College 40
Clinical Trial Overview of Wenzhou Medical College 40
The Back Research Center, Denmark 41
Clinical Trial Overview of The Back Research Center, Denmark 41
Keele University 42
Clinical Trial Overview of Keele University 42
Ziv Medical Center 43
Clinical Trial Overview of Ziv Medical Center 43
Nantes University Hospital 44
Clinical Trial Overview of Nantes University Hospital 44
University of California, San Diego 45
Clinical Trial Overview of University of California, San Diego 45
Five Key Clinical Profiles 46

Appendix 65
Abbreviations 65
Definitions 65
Research Methodology 66
Secondary Research 66
About GlobalData 67
Contact Us 67
Disclaimer 67
Source 67

List of Tables


Sciatic Pain Therapeutics, Global, Clinical Trials by Region, 2014* 7
Sciatic Pain Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Sciatic Pain Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Sciatic Pain Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* 10
Sciatic Pain Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Sciatic Pain Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Sciatic Pain Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13
Sciatic Pain Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 14
Proportion of Sciatic Pain to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 15
Sciatic Pain Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Sciatic Pain Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Sciatic Pain to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 18
Sciatic Pain Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Sciatic Pain Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Sciatic Pain Therapeutics, Global, Clinical Trials by Phase, 2014* 21
Sciatic Pain Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22
Sciatic Pain Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Sciatic Pain Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Sciatic Pain Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 25
Sciatic Pain Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 26
Sciatic Pain Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 27
Sciatic Pain Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 28
Sciatic Pain Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 29
Sciatic Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by Biogen Idec Inc., 2014* 30
Sciatic Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by Teva Pharmaceutical Industries Limited, 2014* 31
Sciatic Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by Regeneron Pharmaceuticals, Inc., 2014* 32
Sciatic Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by Evotec AG, 2014* 33
Sciatic Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by Eurofarma Laboratorios S.A., 2014* 34
Sciatic Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by Clalit Health Services, 2014* 35
Sciatic Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by Calzada Limited, 2014* 36
Sciatic Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital Freiburg, 2014* 37
Sciatic Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by Kaiser Permanente, 2014* 38
Sciatic Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Dental and Craniofacial Research, 2014* 39
Sciatic Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by Wenzhou Medical College, 2014* 40
Sciatic Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by The Back Research Center, Denmark, 2014* 41
Sciatic Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by Keele University, 2014* 42
Sciatic Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by Ziv Medical Center, 2014* 43
Sciatic Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by Nantes University Hospital, 2014* 44
Sciatic Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Diego, 2014* 45

List of Figures


Sciatic Pain Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Sciatic Pain Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Sciatic Pain Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Sciatic Pain Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014* 10
Sciatic Pain Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Sciatic Pain Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Proportion of Sciatic Pain to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 15
Sciatic Pain Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Sciatic Pain Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Sciatic Pain to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 18
Sciatic Pain Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Sciatic Pain Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Sciatic Pain Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
Sciatic Pain Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
Sciatic Pain Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Sciatic Pain Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Sciatic Pain Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 25
Sciatic Pain Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 26
Sciatic Pain Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 27
Sciatic Pain Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 28
Sciatic Pain Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 29
GlobalData Methodology 66

Upcoming Reports:

Spectacles Market - Global Industry Size, Market Share, Trends, Analysis And Forecasts 2012 - 2018
By - Transparency Market Research
Global spectacles market is forecasted to grow at the compounded annual growth rate of 3% and reach the market value of $24 billion by the year 2016. This growth is mainly driven by increasing number of population suffering from refractive errors and rising awareness and cost effectiveness of eye care devices over refractive surgeries. About one third of population aging more than 40 years suffers from refractive errors in US and Western Europe. Occurrence of myopia is higher, around 70-90% in some Asian countries. Compared to men, females are at higher risk of developing...
Synthetic and Bio-Based Butadiene Market: Industry Overview, Applications and Downstream Potential Opportunities, 2010 - 2018
By - Transparency Market Research
1,3-Butadiene, frequently referred to as butadiene, is a simple conjugated diene with the chemical formula C4H6. It is predominantly used as a monomer for producing synthetic rubber in industries. It is produced as a byproduct of the steam cracking used for producing ethylene and olefins; it is also produced from dehydrogenation of n-butane. The global demand of butadiene has been increasing as main application of butadiene is in the production of acrylonitrile butadiene styrene and styrene butadiene rubber which is basically used for manufacturing automotive tires....
Geothermal Energy Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018
By - Transparency Market Research
Geothermal energy is a type of heat energy that is produced in the earth’s core. This energy is utilized in a wide range of applications from power stations to simple pumping systems. Geothermal energy is considered as a renewable source of energy since the water which is captured in the form of heat while extracting geothermal energy is continuously replenished by rainfall and again the heat generated from it can be used. A major concentration of geothermal energy on the planet is in the area bordering the Pacific Ocean and is called the Ring of Fire. ...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

A Health Tech Incubator Started by GE Healthcare
Oct 30, 2014  
For the very first time, a health tech start up campus has been established by GE Healthcare at its headquarters at Helsinki, Finland. This area already has about twenty such healthcare start ups that are working on cloud services, wireless technologies, apps, and sensors that aim at improving healthcare. The main rationale behind such a step is providing opportunities for further...
Net Earnings of DuPont Increases 52% despite Agricultural Turmoil
Oct 29, 2014  
DuPont - The Wilmington, Del-based leading chemical company faced decline of three percent sales to $7.5 billion in the quarter ending of September 30. The company’s third-quarter earnings were increased by 52 percent to $433 million albeit the slow global growth and agricultural downside.   The company witnessed the biggest drags from chemical sales with eight percent...
Appeal for Sanitization in Construction Industry through Government Regulations: CIOB Ghana
Oct 29, 2014  
Rockson Dogbegah - The Chairman of the Chartered Institute of Building Ghana commented that the construction industry needs a thorough cleaning up and assurance of proper growth. Mr. Dogbegah also said that a few factors are extremely important for a proper development in the construction industry. These include keen adherence to standards, supreme sense of professionalism, and sheer pursuance...
Facebook Hints of Rise in Expenses in 2015, Shares Drop
Oct 29, 2014  
Facebook has announced on Tuesday that it is prepping for a dramatic rise in spending in the year 2015. This warning has come combined with a projected slowdown in the company’s revenues after revenues were analyzed at the end of the third quarter of the year. The plans of such hefty spending in the next financial year by the company are indicative of stress in the investor...
China to Invest in UKs Infrastructure Industry
Oct 28, 2014  
As per industry reports, it is expected that in the year 2015, the UK infrastructure will derive benefits from 105 billion pounds of Chinese money. This will involve a host of Chinese machinery suppliers, contractors, and materials producers. The UK government will be spending about half of 225 billion pounds on its own infrastructure. The investors from China will be investing...